News and Announcements
ThinCats Annual Update 2016; Seed Capital Raising Oversubscribed by 29% & Australian Financial Series Licence Secured
- Published January 17, 2017 1:34PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ThinCats Australia (TCA) is Australia’s first Peer to Business (P2B) platform for secured business loans to small and medium sized enterprises (SMEs). Their platform allows for wholesale investors willing to lend fractionally to corporate borrowers through an online marketplace for loans. Key successes for TCA during 2016 include:
- A successful post seed capital raising, oversubscribed by 29%, securing their own Australian Financial Series Licence, welcoming a number of high profile investors to their advisory board, strengthening our management team, increasing product range, growing business referral network, process efficiencies through new technology, automation and embarking on a sophisticated marketing strategy to enable significant growth for 2017.
- ThinCats have invited wholesale investors to register for free membership on the ThinCats Australia platform.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
